UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026602
Receipt number R000030542
Scientific Title A study on tear function tests using a novel tear absorbing strip (SMTube)
Date of disclosure of the study information 2017/06/01
Last modified on 2023/03/22 18:46:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on tear function tests using a novel tear absorbing strip (SMTube)

Acronym

A study on tear function tests using a novel tear absorbing strip (SMTube)

Scientific Title

A study on tear function tests using a novel tear absorbing strip (SMTube)

Scientific Title:Acronym

A study on tear function tests using a novel tear absorbing strip (SMTube)

Region

Japan


Condition

Condition

Dry Eye Disease

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Recently, Echo Electricity Co., Ltd. has successfully developed and initiated a manufacture of Strip Meniscometry Tube (SMTube), which is a medical device used for quantification of the tear meniscus volume residing on the ocular surface. SMTube allows one to measure the tear meniscus volume with five seconds of the testing time for one eye, which is remarkably shorter compared to the conventional Schirmer test requiring five minutes of the testing time.
A clinical efficacy of SMTube has been previously reported, where the testing was performed by a medical doctor under the use of a slit lamp biomicroscopy system. However, the efficacy of SMTube is still unclear if performed by a technical staff in clinics. The objective of this study is to investigate the clinical performance of SMTube when the test is conducted by a technician.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

SMTube testing
Meibomian Gland Dysfunction diagnosis
The Schirmer test
Tear film breakup time measurement

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

SMTube testing (once)
MGD diagnosis (once)
BUT measurement (3 times)
The Schirmer test (once)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

N/A

Key exclusion criteria

A decision should be made by a responsible doctor.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Keiichi
Middle name
Last name Miyasaka

Organization

Echo Electricity Co Ltd

Division name

R&D

Zip code

1230851

Address

6-24-14 Umeda, Adachi, Tokyo

TEL

03-3880-0455

Email

kmfbus@gmail.com


Public contact

Name of contact person

1st name Ryo
Middle name
Last name Okumura

Organization

Mediproduce, Inc.

Division name

Project Manager

Zip code

1070062

Address

2-26-35-8F Minami-Aoyama, Minato, Tokyo

TEL

03-5775-2075

Homepage URL


Email

okumura@mediproduce.com


Sponsor or person

Institute

Echo Electricity Co Ltd

Institute

Department

Personal name



Funding Source

Organization

Echo Electricity Co Ltd

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Haneginomori eye clinic

Address

4-26-4 Daita, Setagaya, Tokyo

Tel

03-6265-8777

Email

mail@hanegi-eye.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

羽根木の森アイクリニック(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 01 Day


Related information

URL releasing protocol

http://www.echo-mf.jp/en.html

Publication of results

Unpublished


Result

URL related to results and publications

http://www.echo-mf.jp/en.html

Number of participants that the trial has enrolled

23

Results

Preliminary data analyses on the test results are currently ongoing.

Results date posted

2020 Year 03 Month 19 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Outpatients to the clinic

Participant flow

The procedure was given upon the reception.

Adverse events

None

Outcome measures

- Descriptive statistics on test scores
- Correlations among the test results

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 03 Month 13 Day

Date of IRB

2017 Year 03 Month 15 Day

Anticipated trial start date

2017 Year 03 Month 23 Day

Last follow-up date

2017 Year 05 Month 31 Day

Date of closure to data entry

2017 Year 05 Month 31 Day

Date trial data considered complete

2017 Year 06 Month 30 Day

Date analysis concluded

2017 Year 07 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 03 Month 17 Day

Last modified on

2023 Year 03 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030542


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name